BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Clinical trial NCT04827719 · COMPLETED

Trial details

NCT number: NCT04827719
Sponsor: Groupe Francophone des Myelodysplasies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Acute Myeloid Leukemia

Start date: 2021-05-01
Primary completion: 2025-01-13
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.